F. Hoffmann-La Roche Ltd: Roche COVID-19 At-Home Test granted FDA Emergency Use Authorization to expand access to rapid self-testing solutions in the United States

Rapid test to support the American public's fight against the COVID-19 pandemic, with availability to purchase over-the-counter (OTC) at pharmacies and retailers nationwideThe COVID-19 At-Home Test uses

Related Keywords

Australia ,Japan ,United States ,Canada ,United Kingdom ,Switzerland ,America ,American ,Nathalie Meetz ,Karl Mahler ,Sabine Borngr ,Gerard Tobin ,Bruno Eschli ,Birgit Masjost ,Actemra Roactemra ,Loren Kalm ,Thomas Schinecker ,Matt Sause ,Genentech ,National Institutes Of Health ,World Health Organization ,Drug Administration ,Sd Biosensor Inc ,European Union ,Roche Group ,Roche Group Media Relations ,Home Test ,National Institutes ,Rapid Acceleration ,Independent Test Assessment Program ,Emergency Use Authorization ,Roche Diagnostics North ,Home Tests ,Antigen Tests ,Self Test Nasal ,Antibody Test ,Use Authorization ,World Health Organization Model Lists ,Essential Medicines ,Dow Jones Sustainability Indices ,Chugai Pharmaceutical ,Federal Food ,Cosmetic Act ,Hoffmann ,Oche ,Covid ,Rome ,Pest ,Granted ,Emergency ,Authorization ,Xpand ,Access ,Rapid ,Self ,Testing ,Solutions ,United ,States ,